Video

Dr. Gore on Hypofractionated Radiation Therapy

Dr. Elizabeth Gore, from the Medical College of Wisconsin, Discusses Hypofractionated Radiotherapy

Elizabeth M. Gore, MD, Professor of Radiation Oncology, Associate Director, Radiation Oncology, Medical College of Wisconsin, discusses the benefits of using hypofractionated instead of conventional radiation therapy.

Hypofractionated radiation is the process of delivering a higher dose of radiation over a shorter period of time. The current standard in locally advanced lung cancer for a curative treatment provides 3D conformal radiation every day for 6 weeks.

The shorter course of treatment that hypofractionated radiotherapy delivers decreases treatment to 15 visits over a 3 week period, providing 3-Gy per fraction for a total of 45-Gy. Data suggest this method is just as effective as conventional radiation, which provides 60-Gy over the course of 6 weeks.

Additionally, hypofractionation is less of a burden for the patient, and is a way to customize care for patients that cannot otherwise tolerate a full course of treatment or are unwilling to come in for treatment every day for 6 weeks.

Related Videos
Erminia Massarelli, MD, PhD, MS
Karen L. Reckamp, MD, MS
Jacob Sands, MD, oncology medical director, International Patient Center, Dana-Farber Cancer Institute; assistant professor, Harvard Medical School
Fred R. Hirsch, MD, PhD, executive director, Center for Thoracic Oncology, The Tisch Cancer Institute at Mount Sinai; Joe Lowe and Louis Price Professor of Medicine (Hematology and Medical Oncology), Icahn School of Medicine at Mount Sinai
Lori Wirth, MD
Tanios Bekaii-Saab, MD, FACP
Moritz Fürstenau, MD
Jun Gong, MD
Thierry Facon, MD
Alicia Morgans, MD, MPH, genitourinary medical oncologist, medical director, Survivorship Program, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School